Current Residents


 No photo or bio currently available




  • Doctor of Medicine, University of Calgary (2018)
  • HBSc. Specialist Major: Behaviour, Genetics & Neurolobiology, University of Toronto (2014)

Interests in Neurology:

  • General Neurology
  • Neuromuscular
  • Neurocognitive
  • Medical Education


  • Cycling
  • Skiing
  • Hiking
  • Yoga
  • Travel
  • Music
  • Art & Design
  • Animal Welfare



  • MD.CM. McGill University (2018)
  • Ph.D. Experimental medicine, McGill University (2014)
  • M.Sc. Experimental medicine, McGill University (2010)
  • B.Sc. (Hons) Biochemistry, University of Ottawa (2007)

Interests in Neurology:

  • Cognitive neurology
  • Brain injury
  • Vascular neurology


  • Soccer
  • Ultimate frisbee
  • Choral singing

Selected Publications

Essalmani R, Susan-Resiga D, Guillemot J, Kim WJ, Sachan V, Awan Z, Chamberland A, Asselin MC, Ly K, Desjardins R, Day R, Prat A and Seidah NG. Thrombin activation of Protein C requires prior processing by endothelial proprotein convertase. Journal of Biological Chemistry. 2017:292(25): 10564-10573

Kim WJ, Zekas E, Lodge R, Susan-Resiga D, Marcinkiewicz E, Essalmani R, Mihara K, Ramachandran R, Asahchop E, Gelman B, Cohen EA, Power C, Hollenberg MD, Seidah NG.Neuroinflammation-induced interactions between protease-activated receptor 1 and proprotein convertases in HIV-associated neurocognitive disorder. Molecular and Cellular Biology. 2015;35(21): 3684-700

Aerts L, Hamelin ME, Rhéaume C, Lavigne S, Couture C, Kim WJ, Susan-Resiga D, Prat A, Seidah NG, Vergnolle N, Riteau B, Boivin G. Modulation of protease activated receptor 1 influences human metapneumovirus disease severity in a mouse model. PloS one. 2013;8(8): e72529

Kim WJ, Seidah NG, Prat A. In utero measurement of heart rate in mouse by noninvasive M-mode echocardiography. Journal of Visualized Experiments. 2013(81): e50994

Kim WJ, Essalmani R, Szumska D, Creemers JWM, Roebroek AJM, D’Orleans-Juste P, Bhattacharya S, Seidah NG and Prat A. Loss of endothelial furin leads to cardiac malformation and early postnatal death. Molecular and Cellular Biology. 2012;32(17): 3382-91



  • Postdoctoral Research Fellowship (Neurodegeneration, Neuroimaging), McGill University, Canada 2017
  • PhD (Clinical Neuroscience), Karolinska Institutet, Sweden 2015
  • MSc (Medical Education), Tehran University of Medical Sciences, Iran 2013
  • MPH (Public Health), Iran University of Medical Sciences, Iran 2010
  • MD (Medicine), Iran University of Medical Sciences, Iran 2009

Interests in Neurology:

  • Neurodegenerative Disorders (Parkinson’s disease, Alzheimer’s disease/other dementias)
  • Movement Disorders
  • Neuroimaging
  • Neuroepidemiology


  • Swimming
  • Table tennis
  • Basketball
  • Travelling
  • Persian calligraphy
  • Neuro-Philosophy

Selected publications:

1. Dawson BK, Fereshtehnejad SM, Anang JB, Nomura T, Rios-Romenets S, Nakashima K, Gagnon JF, Postuma RB. Office-based screening for Dementia in Parkinson’s disease: the Montreal Parkinson’s Risk of Dementia Scale (MoPaRDS) in four longitudinal cohorts. JAMA Neurol. 2018

2. Fereshtehnejad SM, Zeighami Y, Dagher A, Postuma RB. Clinical criteria for subtyping Parkinson’s disease: biomarkers and longitudinal progression. Brain. 2017;140(7):1959-1976.

3. Zeighami Y, Fereshtehnejad SM, Dadar M, Collins DL, Postuma RB, MiĆĄić B, Dagher A. A clinical-anatomical signature of Parkinson’s disease identified with partial least squares and magnetic resonance imaging. Neuroimage. 2017 Dec 19. pii: S1053-8119(17)31074-1.

4. GBD 2015 Neurological Disorders Collaborator Group, 
, Fereshtehnejad SM, 
, Vos T. Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Neurol. 2017;16(11):877-897.

5. Fereshtehnejad SM, Montplaisir JY, Pelletier A, Gagnon JF, Berg D, Postuma RB. Validation of the MDS research criteria for prodromal Parkinson’s disease: Longitudinal assessment in a REM sleep behavior disorder (RBD) cohort. Mov Disord. 2017;32(6):865-873.

6. Fereshtehnejad SM, Postuma RB. Subtypes of Parkinson’s disease: what do they tell us about disease progression? Curr Neurol Neurosci Rep. 2017;17(4):34.

7. Fereshtehnejad SM, Garcia-Ptacek S, Religa D, Holmer J, Buhlin K, Eriksdotter M, Sandborgh-Englund G. Dental care utilization in patients with different types of dementia: A longitudinal nationwide study of 58,037 individuals. Alzheimers Dement. 2017 Jul 8. pii: S1552-5260(17)30233-9.

8. Fereshtehnejad SM, Al-Qassabi A, Postuma RB. Sleep Disturbances in the Prodromal Stage of Parkinson Disease. Curr Treat Options Neurol. 2017;19(6):22.

9. Shams S, Granberg T, Martola J, Charidimou A, Li X, Shams M, Fereshtehnejad SM, Cavallin L, Aspelin P, Wiberg-Kristoffersen M, Wahlund LO. Cerebral microbleeds topography and cerebrospinal fluid biomarkers in cognitive impairment. J Cereb Blood Flow Metab. 2017;37(3):1006-1013.

10. Konijnenberg E, Fereshtehnejad SM, Kate MT, Eriksdotter M, Scheltens P, Johannsen P, Waldemar G, Visser PJ. Early-Onset Dementia: Frequency, Diagnostic Procedures, and Quality Indicators in Three European Tertiary Referral Centers. Alzheimer Dis Assoc Disord. 2017;31(2):146-151.

11. GBD 2016 DALYs and HALE Collaborators, 
, Fereshtehnejad SM, 
, Murray CJL. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1260-1344.

12. Lovas J, Fereshtehnejad SM, Cermakova P, Lundberg C, Johansson B, Johansson K, Winblad B, Eriksdotter M, Religa D. Assessment and Reporting of Driving Fitness in Patients with Dementia in Clinical Practice: Data from SveDem, the Swedish Dementia Registry. J Alzheimers Dis. 2016;53(2):631-8.

13. Tajeddinn W, Fereshtehnejad SM, Seed Ahmed M, Yoshitake T, Kehr J, Shahnaz T, Milovanovic M, Behbahani H, Höglund K, Winblad B, Cedazo-Minguez A, Jelic V, JĂ€remo P, Aarsland D. Association of Platelet Serotonin Levels in Alzheimer’s Disease with Clinical and Cerebrospinal Fluid Markers. J Alzheimers Dis. 2016;53(2):621-30.

14. Fereshtehnejad SM, Shafieesabet M, Farhadi F, Hadizadeh H, Rahmani A, Naderi N, Khaefpanah D, Shahidi GA, Delbari A, Lökk J. Heterogeneous determinants of quality of life in different phenotypes of Parkinson’s disease. PLoS One. 2015;10(9):e0137081.

15. Fereshtehnejad SM, Romenets SR, Anang JB, Latreille V, Gagnon JF, Postuma RB. New clinical subtypes of Parkinson disease and their longitudinal progression: a prospective cohort comparison with other phenotypes. JAMA Neurol. 2015;72(8):863-73.

16. Rios Romenets S, Anang J, Fereshtehnejad SM, Pelletier A, Postuma R. Tango for treatment of motor and non-motor manifestations in Parkinson’s disease: a randomized control study. Complement Ther Med. 2015;23(2):175-84.

17. Religa D, Fereshtehnejad SM, Cermakova P, Edlund AK, Garcia-Ptacek S, Granqvist N, HallbĂ€ck A, KĂ„we K, Farahmand B, Kilander L, Mattsson UB, NĂ€gga K, Nordström P, Wijk H, Wimo A, Winblad B, Eriksdotter M. SveDem, the Swedish Dementia Registry – a tool for improving the quality of diagnostics, treatment and care of dementia patients in clinical practice. PLoS One. 2015;10(2):e0116538.

18. Fereshtehnejad SM, Damangir S, Cermakova P, Aarsland D, Eriksdotter M, Religa D. Comorbidity profile in dementia with Lewy bodies versus Alzheimer’s disease: a linkage study between the Swedish Dementia Registry and the Swedish National Patient Registry. Alzheimers Res Ther. 2014;6(5-8):65.

19. Fereshtehnejad SM, Shafieesabet M, Rahmani A, Farhadi F, Hadizadeh H, Shahidi GA, Delbari A, Lökk J. A novel 6-item screening questionnaire for Parkinsonism: validation and comparison between different instruments. Neuroepidemiology. 2014;43(3-4):178-93.

20. Fereshtehnejad SM, Johnell K, Eriksdotter M. Anti-dementia drugs and co-medication among patients with Alzheimer’s disease: investigating real-world drug use in clinical practice using the Swedish Dementia Quality Registry (SveDem). Drugs Aging. 2014;31(3):215-24.

Selected posters:

1. Network atrophy in early stage predicts longitudinal rate of progression in Parkinson’s disease. In: 23rd Annual Meeting of the Organization for Human Brain Mapping (OHBM), Vancouver, Canada (25-29 June 2017)

2. Clinical Criteria for Subtyping Parkinson’s Disease: Differences in imaging and CSF biomarkers and longitudinal progression. In: 21st International Congress of Parkinson’s Disease and Movement Disorders (MDS), Vancouver, Canada (4-8 June 2017)

3. Hyperechogenicity of substantia nigra for differentiation of idiopathic Parkinson’s disease from other movement disorders: A systematic review and meta-analysis of transcranial ultrasonography (TCS) studies. In: 4th World Parkinson Congress (WPC), Portland, Oregon, USA (20-23 September 2016)

4. Cardiovascular and cerebrovascular disorders are associated with a higher prevalence of parkinsonism: Data from a neuroepidemiologic community-based survey. In: 20th International Congress of Parkinson’s Disease and Movement Disorders (MDS), Berlin, Germany (19-23 June 2016)

5. Clinical subtypes of Parkinson’s disease and disease progression: data-driven comparison of new phenotypes with other cluster solutions. In: 19th International Congress of Parkinson’s Disease and Movement Disorders (MDS), San Diego, CA, USA (14-18 June 2015)

6. Restless legs syndrome (RLS) in patients with Parkinson’s disease: a comparative study on prevalence and clinical characteristics. In: 10th International Congress on Non-Motor Dysfunctions in Parkinson’s Disease and Related Disorders, Nice, France (4-7 December 2014)

7. Diagnosis and treatment in early-onset Alzheimer’s disease patients in Sweden and Denmark: Cross- sectional analyses of data from two dementia registries from specialist clinics. In: Alzheimer’s Association International Conference (AAIC), Copenhagen, Denmark (12-17 July 2014)

8. Devising a new screening instrument for Parkinsonism: comparison of discriminative ability of different questionnaires. In: 18th International Congress of Parkinson’s Disease and Movement Disorders (MDS), Stockholm, Sweden (8-12 June 2014)

9. Anti-dementia drugs and co-medication amongst patients with Alzheimer’s disease: Investigating real-world drug use in clinical practice using the Swedish Dementia Registry (SveDem). In: 22nd Nordic Congress of Gerontology (NKG), Gothenburg, Sweden (25-28 May 2014)

Nutritional status correlates with non-motor and motor symptoms of Parkinson’s disease: A cross-sectional analysis in 143 patients. In: 3rd World Parkinson Congress (WPC), Montreal, Canada (1-4 October 2013)


I am a University of Ottawa Medical School alumna who is thrilled to continue my training here. I am interested in involvement in clinical teaching and research during residency, and I love being active and spending time outdoors.


Doctor of Medicine, University of Ottawa (2017)

Interests in Neurology:

  • General Neurology
  • Stroke
  • MS
  • Epilepsy
  • Medical education


  • Sports (volleyball, basketball, ultimate Frisbee, flag football, ball hockey)
  • Sailing
  • Hiking
  • Puzzles

Selected Publications:

Irish SE, Langohr GD, Willing R, King GJ, Johnson JA. Implications of radial head hemiarthroplasty dish depth on radiocapitellar contact mechanics. J Hand Surg Am. 2015 Apr;40(4):723-9.

Assisted with study assessing a research tool evaluating dysphagia in stroke patients.

Assisted with study correlating stroke site and volume with the presence of clinical dysphagia, dysarthria, or aphasia

Selected Posters:

Irish SE, Langohr GDG, Willing R, King GJ, Johnson JA. Finite Element Analysis of Radial Head Hemiarthroplasty: Implications of Dish Depth on Contact Mechanics. Canadian Orthopedic Association Annual Meeting, Montreal, QC, June 2014.



  • Doctor of Medicine: Tehran University of Medical Sciences- Iran, 1995
  • Neurology Specialty-Board certificate: Tehran University of Medical Sciences, 1999
  • Clinical/Research fellow in Multiple Sclerosis: University of Ottawa, 2016

Interests in Neurology:

  • Neuroimmunology
  • Demyelinative Disease
  • Electrophysiology


  • Spending time with friends and family
  • Travel
  • Biking
  • Iranian traditional music
  • Costco!

Selected Publications:

The Evaluation of MRI Diffusion Values of Active Demyelinating Lesion in Multiple Sclerosis. Poster presentation in CMSC 2016. Poster NI11- Multiple Sclerosis and Related Disorders, Volume 10, 97 – 102

Neuro-Oncology Dilemma: Tumour or Tumefactive Demyelinating Lesion. Multiple Sclerosis and Related Disorders ,Volume 4, Issue 6, November 2015, Pages 555–566

Evaluating Response to Disease Modifying Therapy in Relapsing MS. Expert Rev. Neurother. 15(4), 407–423

Neurosarcoidosis as an MS Mimic: the trials and tribulations of making a diagnosis Multiple Sclerosis and Related Disorders. Multiple Sclerosis and Related Disorders 4 (2015) 414–429

Cerebrospinal Fluid Profile Supporting a Clinical Definite Multiple Sclerosis Diagnosis. Mark Freedman and Mohammed Abdoli. Chapter 8:Primer on Multiple Sclerosis, Second Edition, Edited by Barbara S. Giesser

The Natural Course of Benign MS in the Ottawa MS clinic. Is it possible to predict benign MS? Poster presentation in ECTRIMS, Barcelona, Abstract: P770



I am extremely excited to be working as a neurology resident in Ottawa. My goal is to be an excellent clinician and academic leader, with a focus on medical education. In my spare time, I enjoy music of all types but am a classical musician at heart and love to play the piano. You can frequently find me at outdoor music festivals, ice cream shops, and the gym.


MD, University of Calgary 2017

Interests in Neurology:

  • Stroke
  • Epilepsy
  • Neurocritical care


  • Piano
  • Music festivals
  • Traveling
  • Food + cooking
  • Fitness

Selected publications:

Laneuville, M., Ding, J., Shamy, M., Lum, C., & Dowlatshahi, D. (2017). Intra-arterial milrinone may differentiate fulminant RCVS from vasculitis. Neurology, 89(10), 1093–1095.

Lun R. Calgary Guide to Understanding Disease, 2016: Focal Seizures in the Adult: Pathogenesis and Clinical Findings:

Lun R, Zhang C, Fewell J: Carotid chemoreceptors do not mediate hypoxic-induced gaspingand autoresuscitation in newborn rats. Respir Physiol Neurobiol. 2015 Jul;212-214:33-8. doi: 10.1016/j.resp.2015.04.006. Epub 2015 Apr 20.

Fewell JE, Lun R: Adenosine A1-receptor blockade impairs the ability of rat pups to autoresuscitate from primary apnea during repeated exposure to hypoxia. Physiol Rep. 2015 Aug;3(8). pii: e12458. doi: 10.14814/phy2.12458.

Selected posters:

J.Evans, S.Dey, M.Eesa, P.Eswaradass, R.Lun, Najm.M, M.Horn, A.Neweduk, B.Mcdougall, P.Pordeli, M.V.Jayaraman, M.Goyal, A.M.Demchuk, B.K.Menon Through Thick and Thin: Improved ASPECTS grading and dense vessel detection using simple NCCT post-processing. International Stroke Conference Feb, 2017


 No photo or bio currently available.




  • MRCP(UK), London, UK, 2017
  • MBBCh (Hons), Cardiff University, UK, 2014
  • MSc (by research) Clinical Neurology, Oxford University, UK, 2013

Interests in Neurology:

  • Neuroimmunology and MS
  • Sleep
  • Neurocritical care


  • Travel
  • Biking
  • Swimming
  • Kayaking
  • Sailing
  • Languages
  • (Skiing, working on it)

Selected Publications

1)     Fitzpatrick T, Moores M, Thebault S, Rabinovitch H. One-and-a-half syndrome secondary to transorbital penetrating injury. Neurology 2017 (accepted for publication September 29, 2017).

2)     Thebault S. et al. 2015. ‘Neuronal Antibodies in Children with or without Narcolepsy following H1N1-AS03 Vaccination’. PLoS One. 10(6):e0129555. Available online: []

3)     Thebault S., Simmens A. 2014. ‘Facial nerve palsy at presentation of acute lymphoblastic leukaemia in a 4 year old’. The Welsh Paediatric Journal. (41): 15-17.

4)     Thebault S., Vincent A. Gringras P. 2013. ‘Narcolepsy and H1N1 vaccination: a link?’. Current Opinion in Pulmonary Medicine. 19(6): 587-93. Available online: []

5)     Thebault S. 2013. Is Narcolepsy an antibody-mediated autoimmune disease. MSc (by research) Thesis. University of Oxford. Available online: [] (accessed Oct. 7, 2015)

6)     Kempshall, E., Thebault S., Morgan B.P., Harris C.L., Gallimore A. 2012. ‘Complement-Induced Protection: an explanation for the limitations of cell-based tumour immunotherapies’. Immunology and cell biology 90(9): 869-71. Available online: []

Selected Posters

Thebault S, Tessier D, Lee H, Narayanan S, Tabard-Cossa V, Freedman MS; Elevated Serum and CSF Neurofilament Light Chain levels in patients with aggressive MS normalise following treatment with Bone Marrow Transplant and predict MRI outcomes.  International Congress of Neuroimmunology. Brisbane. August 2018

Thebault S, Tessier D, Stonebridge I, Tabard-Cossa V, Freedman MS; Serum and CSF Neuroflament Light Chain levels normalise following Bone Marrow Transplant in MS Patients. American Academy of Neurology 2018. LA. April 27th 2018

Thebault S, Tessier D, Stonebridge I, Tabard-Cossa V, Freedman MS; Neurofilament Light Chain Levels Significantly Reduced After Bone Marrow Transplant in MS Patient Serum and CSF. ACTRIMS 2018. San Diego. Feb. 2 2018

Thebault S. Woodhall M. Waters P. Vincent A. 2013. ‘Autoantibodies in children with recent onset narcolepsy’. British Paediatric Neurology Association 2013 Annual Meeting. Manchester. Jan. 23, 2013. Abstract available online: []

Thebault S. Waters P., Vincent A. 2012. ‘Putative Autoantibodies in Narcolepsy’. Poster. Wales Undergraduate Medical Conference. Cardiff. Nov. 23, 2012

Thebault S., Waters P., Woodhall M., Clover L., Pettingill R., Nibber A., Vincent A. 2012. ‘Is narcolepsy an autoimmune disease?’. Poster. Nuffield Department of Clinical Neurosciences annual poster day. Oxford. Apr. 27, 2012




Doctor of Medicine, Dalhousie University 2016

Interests in Neurology

  • Stroke
  • Neuro-immunology
  • General Neurology


Running, snowboarding, travel, food

Selected Publications

MacLeod, R.J., Moores, M.E., Beninger, R.J. 2012. Amphetamine stimulates Wnt3 increases in rat nucleus accumbens. Neuroreport 23(14):846-850

Selected Posters

Moores, M., Fenerty, L., Thibault-Halman, G., Kureshi, N., Walling, S., Clarke, D.B. (2015). Use of drains versus no drains after burr-hole evacuation of chronic subdural hematoma. Canadian Neurological Sciences Federation, 50th Annual Congress; Toronto, ON

Moores, M., Darvesh, S., Reid, A., Cash, M. (2013). Association between butyrylcholinesterase and apolipoprotein E genetic polymorphisms and Alzheimer’s disease. Dalhousie IHRTP Health Research Day; Halifax, NS




  • BSc General Science Dalhousie University, 2013 (Biochemistry and Neuroscience)
  • MD McMaster University, 2016

Interests in Neurology:

  • Aerospace Medicine / Occupational Neurology
  • Neuro-Palliative Care
  • General Neurology


  • hockey
  • camping
  • running
  • knitting unnecessarily extravagant projects
  • baking

Academic Projects:

QI: Medication Administration Errors in inpatients with Parkinson Disease (PD) and Parkinson Plus Syndromes at TOH. The Ottawa Hospital / University of Ottawa. 2017 – ongoing.

QI: Development of The Program for Improvement if Medical Education (PRIME) Working Group, introducing first-year medical students to QI methodology. McMaster University, 2014-2016

QI: Incidence and implication of concussion in university varsity athletics: A prospective initiative for concussion management. Dalhousie University, 2012-2013.


Charlesworth, L. Neurology International Residents Videoconference and Exchange (NIRVE) Imaging Challenge, Dec 2017: CNS Toxoplasmosis.

Brown, A., Law, M., Smrke, A., Goswami, N., Baron, M., Charlesworth, L., Stackaruk, M., Greenway, M. (2015) Engaging Learners in a Medical Education Context for Early Introduction of Quality Improvement (QI) Methodology: The Program for Improvement in Medical Education” (PRIME).

D’Addazio, R., Laakso, L., Charlesworth, L., Catapano, M., Kwan, M., Luce, J., Wright, J., Law, M. P., Greenway, M. (2015) Understanding the Admission Process at a Local Rehabilitation Centre for Improved Management of Secondary Stroke Prevention.



HBSc Applied Biomolecular Science, Lakehead University, 2011

Doctor of Medicine, NOSM, 2015

Interests in Neurology:

General Neurology


Reading, travelling, working out, camping, country music

Selected Publications/Posters: a work in progress




  • Medical Degree: McMaster University, Hamilton, ON
  • Bachelor of Science: University of Ottawa, Ottawa, ON

Interests in Neurology:

  • Neuroimmunology
  • Acute Neurology
  • Healthcare economics


  • Sports: Basketball, volleyball, tennis, biking, golf
  • Music: Hip hop, R&B, Jazz, Indie
  • Fine dining: Everything and any time

Research Articles:

1. Bose G, Graveline J, Mendonça M, Baptista M, Nagel S, Dowlatshahi D. Systematic review of direct oral anticoagulants in treatment of cerebral venous thrombosis [PENDING]

2. Bose G, Freedman MS, Rush C, Bowman M, Atkins H. Safety and efficacy of IV cladribine versus alemtuzumab in aggressive multiple sclerosis: a retrospective cohort study [PENDING]

3. Bose G, Atkins H. Autologous stem cell transplantation for multiple sclerosis; has its time finally come? Current Hematologic Malignancy Reports. [PENDING]

4. Bose G, Atkins H, Bowman M, Freedman MS. Autologous haemopoietic stem cell transplantation improves fatigue in multiple sclerosis. [PENDING]

Research Posters:

American Academy of Neurology Apr 2018. Bose G, Freedman MS, Rush C, Bowman M, Atkins H. Safety and efficacy of IV cladribine versus alemtuzumab in aggressive multiple sclerosis: a retrospective cohort study – Poster, Presenter

Americas Committee for Treatment and Research in MS (ACTRIMS) Feb 2017. Bose G, Atkins H, Bowman M, Freedman M. Reduction in fatigue following immunoablation and autologous haemopoietic stem-cell transplantation treatment of severe multiple sclerosis. – Poster, Presenter

16th Biennial Canadian Neuro-Oncology Meeting Jun 2014. Pier 21 Convention Centre, Halifax, NS. Bose G, Algird A, Lach B, Whitton A, Torres-Trejo A, Bennardo M, Reddy K. Clival chordoma metastatic to right lateral ventricle: a case report. — Poster, Presenter



  • MD, McGill University (2015)
  • Med-p, McGill University (2011)

Interest in Neurology:

  • Movement disorders
  • Cognitive neurology
  • Vascular neurology


  • Hiking
  • Cooking
  • Classic guitar
  • Cross-country & downhill skiing

Selected Publications:

Bose G, Graveline J, Dowlatshahi D (2017). Systematic Review of Direct Oral Anticoagulants in Treatment of Cerebral Venous Thrombosis. Protocol published in the PROSPERO International prospective register of systematic reviews (NHS) (

Selected Posters:

Graveline J, La Piana R, Del Pilar Cortes M, Tampieri D (2014). Diagnosis and Management of Intra- and Extra-Cranial Dissecting Aneurysms: Focus on CTA as a Non-Invasive Diagnostic Technique. Annual Meeting of the American Society of Neuroradiology, Montreal, CA.

Graveline J, La Piana R, Del Pilar Cortes M, Tampieri D (2013). Occurrence, Diagnosis and Management of Intra- and Extra-Cranial Dissecting Aneurysms. Denis Melancon Neuroradiology Conference, Montreal Neurological Institute, Montreal, CA.

Graveline J, Nguyen K, Rymar V, Sadikot AF (2012). Role of the Neurotrophin BDNF in the pathogenesis of Huntington’s Disease. McGill Faculty of Medicine Research Day, Montreal, CA.


No photo or bio currently available.


No photo or bio currently available




  • MDCM, McGill University, 2014
  • BSc Honours Physiology, McGill University, 2010

Interests in Neurology:

  • Epilepsy


  • Travel
  • Theatre

Selected Publications:

Kyriakopoulos P, Fedyk M, Shamy M. Translating Futility. CMAJ. 2017 Jun 12;189(23):E805-E806.

Kyriakopoulos P, Oskoui M, Dagenais L, Shevell MI. Term neonatal encephalopathy antecedent cerebral palsy: A retrospective population-based study. Eur J Paediatr Neurol. 2013 May;17(3):269-73.

Kyriakopoulos P, Oskoui M, Dagenais L, Shevell MI. Does Antenatal Tobacco or Alcohol Exposure Influence a Child’s Cerebral Palsy? A Population-Based Study. Pediatr Neurol. 2012 Nov;47(5):349-54.

Seo JH, Zilber Y,Babayeva S, Liu J, Kyriakopoulos P, De Marco P, Merello E, Capra V, Gros P, Torban E. Mutations in the planar cell polarity gene, Fuzzy, are associated with neural tube defects in humans. Hum Mol Genet. 2011 Nov 15;20(22):4324-33

Selected Posters:

Kyriakopoulos P, Oskoui M, Dagenais L, Shevell M. Antenatal Toxin Exposure and Cerebral Palsy: a Population-Based Study. 2011. McGill University Medical Student Research Day.



  • MSc, Epidemiology and Public Health, University of Ottawa (Ongoing)
    • Clinical Investigator Stream
  • MD, University of British Columbia (2014)
  • BSc (Hons), University of British Columbia (2010)

Interests in Neurology:

  • Ischemic Stroke
  • Intracerebral Hemorrhage
  • Endovascular Therapy

 Textbook Chapters:

Yogendrakumar V, Goldstein JN, Dowlatshahi D. Expansion of Intracerebral Hemorrhage. In Complications of Acute Stroke: A Concise Guide to Prevention, Recognition, and Management. Editors: Behrouz R, Birnbaum L. (Accepted, Publication in Press).

Selected Publications:

Yogendrakumar V, Smith E, Demchuk AM, Aviv RI, Rodriguez-Luna D, Molina CA, Blas YA, Dzialowski I, Kobayashi A, Boulanger J, Lum C, Gubitz G, Padma V, Roy J, Kase CS, Bhatia R, Ali M, Lyden P, Hill MD, Dowlatshahi D. Lack of Early Improvement Predicts Poor Outcome Following Acute Intracerebral Hemorrhage. Crit Care Med. 2018 Jan 4. doi: 10.1097/CCM.0000000000002962.

Yogendrakumar V, Demchuk AM, Aviv RI, Rodriguez-Luna D, Molina CA, Blas YS, Dzialowski I, Kobayashi A, Boulanger J, Lum C, Gubitz G, Padma V, Roy J, Kase CS, Bhatia R, Hill MD, Dowlatshahi D. Location of Haemorrhage Predicts Haematoma Expansion. Euro Stroke Journal. 2017;2:257-263.

Yogendrakumar V, Patro S, Dowlatshahi D, Stotts G, Iancu D. Calcified Thrombus Mimics Patent Middle Cerebral Artery (MCA) on CT Angiogram. Practical Neurology. 2017;17:307-309.

Dowlatshahi D, Yogendrakumar V, Aviv RI, Rodriguez-Luna D, Molina CA, Blas YS, Dzialowski I, Czlonkowska A, Boulanger J, Lum C, Gubitz G, Padma V, Roy J, Kase CS, Bhatia R, Hill MD, Demchuk AM. Small Intracerebral Hemorrhage Have a Low Spot Sign Prevalence and Are Less Likely to Expand. Int J Stroke. 2016; 11(2):191-197.

Selected Awards:

  • Queen Elizabeth II Graduate Scholarship in Science and Technology –2017
  • European Stroke Organization Young Investigator Award –2017
  • uOttawa Faculty of Medicine: PGME Clinical Scholar Award –2016



Bachelor’s of Science (Physiology Major), McGill University, 2008

Doctorat of Medicine, Université de Montréal, 2014

Interests in Neurology: General Neurology (so everything!)

Hobbies: Travel, Swimming, Skating, Spinning, Gastronauts (aka eating)

Selected Publications: 

Laneuville, M., Ding, J., Shamy, M., Lum, C., & Dowlatshahi, D. (2017). Intra-arterial milrinone may differentiate fulminant RCVS from vasculitis. Neurology, 89(10), 1093–1095.

Selected Posters:

Laneuville M, Woulfe J, Dyment D, Warman-Chardon J. “LDB3/ZASP-related Myofibrillar Myopathy Associated with Marked Phenotypic Variability”

  • 3rd Ottawa International Conference on Neuromuscular Biology, Disease and Therapy, Sept 2015.
  • Ottawa Resident Research Day, June 2016.
  • World Muscle Society Congress, Oct 2016.



Doctor of Medicine, Queen’s University, 2014

Interests in Neurology

  • Stroke
  • Neuro-critical care
  • Neuro-ophthalmology


Running, cooking, travel, wine

Selected Publications

1) Fitzpatrick T, Moores M, Thebault S, Rabinovitch H. One-and-a-half syndrome secondary to transorbital penetrating injury. Neurology 2017 (accepted for publication September 29, 2017)

 2) Fitzpatrick T, Carrier M, Le Gal G. Cancer, atrial fibrillation, and stroke. Thrombosis Research 2017;9(155):101-105.

 3) Fernando SM, Fitzpatrick T, Hurdle H, Anand A, Skinner CR, Boyd KU, Dumitrascu G, Hooper J. Recurrent non-epileptiform seizure-like phenomena secondary to propofol administration. Canadian Journal of Anesthesia 2017;64(7):783-785.

 4) Fitzpatrick T, Lelli D. (2017). Case of the month: Lateral Medullary Syndrome. Canadian Neuro-Ophthalmology Group (

5) Sudenis T, Hall K, Cartotto RC. Enteral nutrition: What the dietitian prescribes isn’t what the patient gets! Journal of Burn Care and Research 2015;36(2):297-305.

6) Ashbury T, Milne B, McVicar J, Holden R, Phelan R, Sudenis T, VanDenkerkhof E. A clinical tool to predict adverse behaviour in children at the induction of anesthesia. Canadian Journal of Anesthesia 2014;61(6):543-50.

7) Boulos MI, Umapathy K, Shokrollahi P, McConville KMV, Sudenis T, Jewell DR, Krishnan S, Murray BJ. Automated detection of nocturnal slow eye movements modulated by selective serotonin reuptake inhibitors. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2011;35(1):126-130.


Selected Posters

1) Fitzpatrick T, Gocan S, Wang C, Bourgoin A, Dowlatshahi D, Stotts G, Shamy M. (2017). How experts diagnose TIA: a systematic review. Poster presentation at The Canadian Stroke Congress 2017, Calgary, CA.

 2) Fitzpatrick T, Gocan S, Shamy M. (2017). How experts diagnose TIA: a systematic review. Poster presentation at the University of Ottawa Department of Medicine Research Day, Ottawa, CA.

 3) Fitzpatrick T. (2017). Revascularization for Acute Basilar Artery Occlusion. Canadian Stroke Consortium Resident Review Course, Montreal, CA.

 4) Sudenis T, Hall K, Cartotto RC. (2013). Enteral nutrition: what the dietician prescribes isn’t what the patient gets! Journal of Burn Care & Research, 34(2), S152. Annual Meeting of the American Burn Association, Palm Springs, USA.

 5) Chung K, Sudenis T, Maniatis K, Li Z, & Cartotto RC. (2013). Compensating with a “correction factor” to improve delivery of prescribed enteral nutrition in burn patients. Poster presentation at the Medical Student Annual Research Showcase, Kingston, CA.

 6) Boulos MI, Umapathy K, Shokrollahi P, Krishnan S, McConville KMV, Sudenis T, Jewell DR, & Murray BJ. (2010). Serotonergic modulation of eye movements in sleep assessed by automated detection. Neurology,74(9;Suppl. 2), A274-5. Annual Meeting of the American Academy of Neurology, Toronto, CA.

7) Boulos MI, Umapathy K, Shokrollahi P, Krishnan S, McConville KMV, Sudenis T, Jewell DR, & Murray BJ. (2010). Slow eye movements in light sleep on the maintenance of wakefulness test as a marker of sleepiness. Neurology, 74(9;Suppl. 2), A275. Annual Meeting of the American Academy of Neurology, Toronto, CA.



BA & Sc -  Mcgill University 2011

MD – McMaster University 2014

Interests in Neurology

  • Neuro-Ophthalmology
  • Neuro-Infectious Diseases
  • General Neurology


  • Camping, hiking, backpacking trips
  • Painting, DYI projects
  • Triathlons

Selected Publications

Laneuville, M., Ding, J., Shamy, M., Lum, C., & Dowlatshahi, D. (2017). Intra-arterial milrinone may differentiate fulminant RCVS from vasculitis. Neurology, 89(10), 1093–1095.

Ding J, Easton A. Neuroinfectious diseases course. Advances in clinical neurosciences and rehabilitation. 16:Nov-Jan 2017.

Selected Posters

  • Ding J, Muckle W, Skinner C, Turnbull J. Neurons on Wheels Goes to Homeless Shelters. 2017

  • Ding J, Mallick R, Carpentier J, McBain K, Gaspard N, Westover MB, et al. Resident competency using the ACNS Critical Care EEG Terminology. 2017




  • MDCM, McGill University (2013)
  • BSc Neuroscience, McGill University (2008)
  • BSc Computer Science, McGill University (2005)

Interests in Neurology:

  • Headache


  • yoga
  • cooking
  • traveling
  • non-fiction writing


Medrea I, Christie S. Comparison of Propranolol versus Placebo Use in Reduction of Migraine Days by Frequency of Migraine Episodes, Systematic Review and Individual Patient Level Data Meta-Analysis. International Headache Congress 2017, Vancouver.

Medrea I, Christie S. Chronic Migraine History and Clinical Implications Headache Currents IN PUBLICATION

Medrea I, Cullen KE. Multisensory integration in early vestibular processing in mice: the encoding of passive vs. active motion. J Neurophysiol. 2013 Dec;110(12):2704-17